JANE STREET GROUP, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2023$54,684
-68.3%
17,697
-56.6%
0.00%
Q4 2022$172,660
+439.6%
40,818
+268.5%
0.00%
Q2 2022$32,000
-70.9%
11,076
-1.6%
0.00%
Q1 2021$110,000
-91.1%
11,257
-90.7%
0.00%
Q4 2020$1,237,000
+13.2%
120,621
+11.4%
0.00%
Q3 2020$1,093,000
+300.4%
108,246
+313.4%
0.00%
Q2 2020$273,000
+150.5%
26,183
+103.6%
0.00%
Q1 2020$109,000
-89.8%
12,863
-89.5%
0.00%
-100.0%
Q4 2019$1,068,000
+228.6%
122,066
+304.9%
0.00%0.0%
Q3 2019$325,000
-83.6%
30,150
-41.0%
0.00%
-66.7%
Q1 2019$1,981,000
+248.8%
51,084
+83.1%
0.00%
+200.0%
Q4 2018$568,000
-26.9%
27,896
+64.6%
0.00%
-50.0%
Q3 2018$777,000
-67.7%
16,944
-58.4%
0.00%
-66.7%
Q2 2018$2,409,000
+53.3%
40,717
+156.1%
0.01%
+20.0%
Q4 2017$1,571,000
-56.4%
15,901
-47.2%
0.01%
-58.3%
Q3 2017$3,603,000
-44.1%
30,090
-59.2%
0.01%
-47.8%
Q2 2017$6,451,000
+352.1%
73,804
+246.8%
0.02%
+228.6%
Q3 2016$1,427,000
+23.0%
21,279
+43.8%
0.01%0.0%
Q4 2015$1,160,000
-59.9%
14,800
-40.3%
0.01%
-63.2%
Q2 2015$2,894,000
+163.6%
24,785
+327.1%
0.02%
+137.5%
Q4 2014$1,098,000
+10.5%
5,803
+39.3%
0.01%
-20.0%
Q3 2014$994,000
+392.1%
4,167
+114.5%
0.01%
+400.0%
Q1 2014$202,0001,9430.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders